Olanzapine-Associated Hypothermia

Psychosomatics

Volumn 45, Issue 2, 2004, Pages 135-139

  Blass, David M ^a,b   Chuen, Michelle ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OLANZAPINE;

ADULT; AGED; ARTICLE; ATAXIA; BIPOLAR DISORDER; BRADYCARDIA; CASE REPORT; CLINICAL FEATURE; DELIRIUM; DISORIENTATION; FATIGUE; FEMALE; HUMAN; HYPOTHERMIA; MALE; RARE DISEASE; SHIVERING; SIDE EFFECT; SLURRED SPEECH;

EID: 1442276449     PISSN: 00333182     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.psy.45.2.135     Document Type: Letter

References (28)

1. Clark WG, Lipton JM: Changes in body temperature after administration of amino acids, peptides, dopamine, neuroleptics and related agents, II. Neurosci Biobehav Rev 1985; 9:299-371
2. Dilsaver SC: Effects of neuroleptics on body temperature. J Clin Psychiatry 1988; 49:78-79
3. Schwaninger M, Weisbrod M, Schwab S, Schroder M, Hacke W: Hypothermia induced by atypical neuroleptics. Clin Neuropharmacol 1998; 21:344-346
4. Lin MT, Chem YF, Wang Z, Wang HS: Effects of apomorphine on thermoregulatory responses of rats to different ambient temperatures. Can J Physiol Pharmacol 1979; 57:469-475
5. Guze BH, Baxter LR: Neuroleptic malignant syndrome. N Engl J Med 1985; 313:163-166
6. Pelonero AL, Levenson JL, Pandurangi AK: Neuroleptic malignant syndrome: a review. Psychiatr Serv 1998; 49:1163-1172
7. Hasan S, Buckley P: Novel antipsychotics and the neuroleptic malignant syndrome: a review and critique. Am J Psychiatry 1998; 155:1113-1116
8. Karagianis JL, Phillips LC, Hogan KP, LeDrew KK: Clozapine-associated neuroleptic malignant syndrome: two new cases and a review of the literature. Ann Pharmacother 1999; 33:623-630
9. Philibert RA, Adam LA, Frank FM, Carney-Doebbeling C: Olanzapine usage associated with neuroleptic malignant syndrome. Psychosomatics 2001; 42:528-529
10. Dave M: Two cases of risperidone-induced neuroleptic malignant syndrome (letter). Am J Psychiatry 1995; 152:1233-1234
11. Sing KJ, Ramaekers GMGI, Van Harten PN: Neuroleptic malignant syndrome and quefiapine (letter). Am J Psychiatry 2002; 159:149-150
12. Young DM: Risk factors for hypothermia in psychiatric patients. Ann Clin Psychiatry 1996; 8:93-97
13. Heh CW, Herrera J, DeMet E, Potkin S, Costa J, Sramek J, Hazlett E, Buchsbaum MS: Neuroleptic-induced hypothermia associated with amelioration of psychosis in schizophrenia. Neuropsychopharmacology 1988; 1:149-156
14. Laborit HM: Clinical hypothermia, in Body Temperature Regulation: Drug Effects and Therapeutic Implications. Edited by Lomax P, Schonbaum E. New York, Dexter, 1979, pp 595-611
15. Weinberg AD: Hypothermia. Ann Emerg Med 1993; 22:370-377
16. Hagg S, Mjorndal T, Lindqvist L: Repeated episodes of hypothermia in a subject treated with haloperidol, levomepromazine, olanzapine, and thioridazine. J Clin Psychopharmacol 2001; 21:113-115
17. Parris C, Mack JM, Cochiolo JA, Steinmann AF, Tietjen J: Hypothermia in 2 patients treated with atypical antipsychotic medication. J Clin Psychiatry 2001; 62:61-63
18. Phan TG, Yu RY, Hersch MI: Hypothermia induced by risperidone and olanzapine in a patient with Prader-Willi syndrome. Med J Aust 1998; 169:230-231
19. Tanis BC, Westendorp GJ, Smelt HM: Effect of thyroid substitution on hypercholesterolaemia in patients with subclinical hypothyroidism: a reanalysis of intervention studies. Clin Endocrinol (Oxf) 1996; 44:643-649
20. Staub J, Althaus BU, Engler H, Ryff AS, Trabucco P, Marquardt K, Burckhardt D, Girard J, Weintraub BD: Spectrum of subclinical and overt hypothyroidism: effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues. Am J Med 1992; 92:631-642
21. Cooper DS, Halpern R, Wood LC, Levin AA, Ridgway EC: L-Thyroxine therapy in subclinical hypothyroidism: a double-blind, placebo-controlled trial. Ann Intern Med 1984; 101:18-24
22. Loprinzi L, Barton DL, Sloan JA, Zahasky KM, Smith de AR, Pruthi S, Novotny PJ, Perez EA, Christensen BJ: Pilot evaluation of gabapentin for treating hot flashes. Mayo Clin Proc 2002; 77:1159-1163
23. Guttuso TJ Jr: Gabapentin's effects on hot flashes and hypothermia. Neurology 2000; 54:2161-2163
24. Physicians' Desk Reference, 56th ed. Montvale, NJ, Medical Economics Co, 2002, p 2655
25. 2 receptor occupancy of olanzapine in schizophrenia: a PET investigation. Am J Psychiatry 1998; 155:921-928
26. Oerther S, Ahlenius S: Atypical antipsychotics and dopamine D(1) receptor agonism: an in vivo experimental study using core temperature measurements in the rat. J Pharmacol Exp Ther 2000; 292:731-736
27. Yamawaki S, Lai H, Horita A: Dopaminergic and serotonergic mechanisms of thermoregulation: mediation of thermal effects of apomorphine and dopamine. J Pharmacol Exp Ther 1983; 227:383-388
28. Schwartz PJ, Wehr TA, Rosenthal NE, Bartko JJ, Oren DA, Luetke C, Murphy DL: Serotonin and thermoregulation: physiologic and pharmacologic aspects of control revealed by intravenous m-CPP in normal human subjects. Neuropsychopharmacology 1995; 13:105-115